Skip to main content
PMC home page
Food Science and Biotechnology logoLink to Food Science and Biotechnology
. 2016 Jun 30;25(3):861–866. doi: 10.1007/s10068-016-0142-3

Kombucha tea prevents obese mice from developing hepatic steatosis and liver damage

Jeongeun Hyun 2, Youngjae Lee 2, Sihyung Wang 2, Jinnyun Kim 1, Jieun Kim 2, JaeHo Cha 1, Young-Su Seo 1, Youngmi Jung 2,✉
PMCID: PMC6049161  PMID: 30263346

Abstract

Nonalcoholic fatty liver disease (NAFLD) is associated with the increased accumulation of hepatocellular lipids. Although Kombucha tea (KT) has emerged as a substance protecting the liver from damage, the effects of KT in NAFLD remain unclear. Hence, we investigated whether KT influenced hepatic steatosis. Db/db mice were fed either control or methionine/choline-deficient (MCD) diets for 4 weeks. The MCD diet group was treated with KT or water for 3 weeks. KT treatment alleviated macrovesicular steatosis compared to the MCD-fed group. The levels of triglyceride, ALT, and AST also decreased in the KT+MCD-treated db/db mice. RNA expression in the MCD+KT group showed reduced triglyceride synthesis and uptake of fatty acids. Immunostaining and western blot assays for active caspase-3 demonstrated a lower level of apoptosis in the MCD+KT than in the MCD group. These results demonstrate that KT attenuated lipid accumulation and protected the liver from damage, promoting liver restoration in mice.

Keywords: Kombucha tea, nonalcoholic fatty liver disease, liver protection, db/db mouse

References

  • 1.Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, Baron M, Lucas A, Tailleux A, Hum DW, Ratziu V, Cariou B, Hanf R. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis. Hepatology. 2013;58:1941–1952. doi: 10.1002/hep.26461. [DOI] [PubMed] [Google Scholar]
  • 2.Syn WK, Teaberry V, Choi SS, Diehl AM. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin. Liver Dis. 2009;29:200–210. doi: 10.1055/s-0029-1214375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fon Tacer K, Rozman D. Nonalcoholic Fatty liver disease: Focus on lipoprotein and lipid deregulation. J. Lipids. 2011;2011:783976. doi: 10.1155/2011/783976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tolman KG, Dalpiaz AS. Treatment of non-alcoholic fatty liver disease. Ther. Clin. Risk Manag. 2007;3:1153–1163. [PMC free article] [PubMed] [Google Scholar]
  • 5.Chitturi S. Treatment options for nonalcoholic fatty liver disease. Therap. Adv. Gastroenterol. 2008;1:173–189. doi: 10.1177/1756283X08096951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: Not all lipids are created equal. Expert Rev. Gastroenterol. Hepatol. 2009;3:445–451. doi: 10.1586/egh.09.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD) Prog. Lipid Res. 2009;48:1–26. doi: 10.1016/j.plipres.2008.08.001. [DOI] [PubMed] [Google Scholar]
  • 8.Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, Laitinen S, Kolak M, Fisher RM, Hamsten A, Auvinen P, Yki-Jarvinen H. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 2008;294:G1281–G1287. doi: 10.1152/ajpgi.00074.2008. [DOI] [PubMed] [Google Scholar]
  • 9.Dorn C, Riener MO, Kirovski G, Saugspier M, Steib K, Weiss TS, Gabele E, Kristiansen G, Hartmann A, Hellerbrand C. Expression of fatty acid synthase in nonalcoholic fatty liver disease. Int. J. Clin. Exp. Pathol. 2010;3:505–514. [PMC free article] [PubMed] [Google Scholar]
  • 10.Dufresne C, Farnworth E. Tea, Kombucha, and health: A review. Food Res. Int. 2000;33:409–421. doi: 10.1016/S0963-9969(00)00067-3. [DOI] [Google Scholar]
  • 11.Bhattacharya S, Gachhui R, Sil PC. Effect of Kombucha, a fermented black tea in attenuating oxidative stress mediated tissue damage in alloxan induced diabetic rats. Food Chem. Toxicol. 2013;60:328–340. doi: 10.1016/j.fct.2013.07.051. [DOI] [PubMed] [Google Scholar]
  • 12.Chen C, Liu B. Changes in major components of tea fungus metabolites during prolonged fermentation. J. Appl. Microbiol. 2000;89:834–839. doi: 10.1046/j.1365-2672.2000.01188.x. [DOI] [PubMed] [Google Scholar]
  • 13.Ponmurugan P, Muthumani T, Jayabalan R, Swaminathan K. A comparative study on Kombucha tea and black tea. J. Plantation Crops. 2006;34:688–693. [Google Scholar]
  • 14.Bhattacharya S, Gachhui R, Sil PC. Hepatoprotective properties of Kombucha tea against TBHP-induced oxidative stress via suppression of mitochondria dependent apoptosis. Pathophysiology. 2011;18:221–234. doi: 10.1016/j.pathophys.2011.02.001. [DOI] [PubMed] [Google Scholar]
  • 15.Greenwalt CJ, Ledford RA, Steinkraus KH. Determination and characterization of the antimicrobial activity of the fermented tea Kombucha. LWT-Food Sci. Technol. 1998;31:291–296. doi: 10.1006/fstl.1997.0354. [DOI] [Google Scholar]
  • 16.Srihari T, Karthikesan K, Ashokkumar N, Satyanarayana U. Antihyperglycaemic efficacy of kombucha in streptozotocin-induced rats. J. Funct. Foods. 2013;5:1794–1802. doi: 10.1016/j.jff.2013.08.008. [DOI] [Google Scholar]
  • 17.Pauline T, Dipti P, Anju B, Kavimani S, Sharma SK, Kain AK, Sarada SK, Sairam M, Ilavazhagan G, Devendra K, Selvamurthy W. Studies on toxicity, anti-stress and hepato-protective properties of Kombucha tea. Biomed. Environ. Sci. 2001;14:207–213. [PubMed] [Google Scholar]
  • 18.Murugesan GS, Sathishkumar M, Jayabalan R, Binupriya AR, Swaminathan K, Yun SE. Hepatoprotective and curative properties of Kombucha tea against carbon tetrachloride-induced toxicity. J. Microbiol. Biotechn. 2009;19:397–402. doi: 10.4014/jmb.0806.374. [DOI] [PubMed] [Google Scholar]
  • 19.Sai Ram M, Anju B, Pauline T, Dipti P, Kain AK, Mongia SS, Sharma SK, Singh B, Singh R, Ilavazhagan G, Kumar D, Selvamurthy W. Effect of Kombucha tea on chromate (VI)-induced oxidative stress in albino rats. J. Ethnopharmacol. 2000;71:235–240. doi: 10.1016/S0378-8741(00)00161-6. [DOI] [PubMed] [Google Scholar]
  • 20.Jayabalan R, Malbaša RV, Lonèar ES, Vitas JS, Sathishkumar M. A review on Kombucha tea-microbiology, composition, fermentation, beneficial effects, toxicity, and tea fungus. Compr. Rev. Food Sci. F. 2014;13:538–550. doi: 10.1111/1541-4337.12073. [DOI] [PubMed] [Google Scholar]
  • 21.Wang S, Lee Y, Kim J, Hyun J, Lee K, Kim Y, Jung Y. Potential role of hedgehog pathway in liver response to radiation. PLoS ONE. 2013;8:74141. doi: 10.1371/journal.pone.0074141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366–1374. doi: 10.1002/hep.21655. [DOI] [PubMed] [Google Scholar]
  • 23.Meissner M, Herrema H, van Dijk TH, Gerding A, Havinga R, Boer T M M, Reijngoud D-J, Groen AK, Kuipers F. Bile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance rate. PLoS ONE. 2011;6:24564. doi: 10.1371/journal.pone.0024564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Takahashi Y, Soejima Y, Fukusato T. Animal Models for Nonalcoholic fatty liver disease. In: Mullin GE, Cheskin LJ, Matarese LE, editors. Integrative Weight Management. New York, NY, USA: Springer; 2014. [Google Scholar]
  • 25.Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS. Pancaspase inhibitor VX166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology. 2009;50:1421–1430. doi: 10.1002/hep.23167. [DOI] [PubMed] [Google Scholar]
  • 26.Xin H-G, Zhang B-B, Wu Z-Q, Hang X-F, Xu W-S, Ni W, Zhang R-Q, Miao X-H. Treatment with baicalein attenuates methionine choline deficient dietinduced non-alcoholic steatohepatitis in rats. Eur. J. Pharmacol. 2014;738:310–318. doi: 10.1016/j.ejphar.2014.06.006. [DOI] [PubMed] [Google Scholar]
  • 27.Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J. Hepatol. 2010;53:724–731. doi: 10.1016/j.jhep.2010.04.033. [DOI] [PubMed] [Google Scholar]
  • 28.Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, Bammler TK, Beyer RP, Montine TJ, Yeh MM. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. Lab. Invest. 2010;90:1704–1717. doi: 10.1038/labinvest.2010.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wang S, Hyun J, Youn B, Jung Y. Hedgehog signaling regulates the repair response in mouse liver damaged by irradiation. Radiat. Res. 2012;179:69–75. doi: 10.1667/RR3091.1. [DOI] [PubMed] [Google Scholar]

Articles from Food Science and Biotechnology are provided here courtesy of Springer

RESOURCES